Protagenic Therapeutics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $8.7M | — |
| Jun 2022 | — | $8.3M | — |
| Sep 2022 | — | $7.4M | — |
| Dec 2022 | — | $6.9M | — |
| Mar 2023 | — | $6.4M | — |
| Jun 2023 | — | $5.4M | — |
| Sep 2023 | — | $4.2M | — |
| Dec 2023 | — | $3.7M | — |
| Mar 2024 | — | $-1.8M | $1.6K |
| Jun 2024 | — | $-1.8M | $713.6K |
| Sep 2024 | — | $-2.5M | $71.4K |
| Dec 2024 | — | $-3.3M | $79.6K |
| Mar 2025 | — | $-5.0M | $14.5K |
| Jun 2025 | — | $-4.0M | $4.1M |
| Sep 2025 | — | $-4.7M | $2.7M |
| Dec 2025 | — | $-2.4M | $2.2M |
| Mar 2026 | — | $2.6M | $1.5M |
| Jun 2026 | — | $1.7M | $566.0K |